EUVIMEDObjevte EUVIMED
Editorial

Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males

Nicole E Chin, Andrea Hui Austin

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.7844 ↗

At a glance

Editorial in Journal of Drugs in Dermatology, 2024. Written by Nicole E Chin and 1 co-authors. Major MEDLINE topics: Tranexamic Acid, Melanosis. Cited 1 times so far (Crossref).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Tranexamic acid (TXA) is an antifibrinolytic medication largely known for its efficacy in managing menorrhagia, or heavy periods, making it a medication predominantly used by women.

Subjects

MeSH terms (MEDLINE)

Tranexamic AcidMelanosisMaleHumansAdministration, CutaneousTreatment Outcome

Substances

Tranexamic Acid

Cite

APA

Chin, N. E., & Austin, A. H. (2024). Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7844

Vancouver

Chin NE, Austin AH. Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7844

BibTeX
@article{Chin2024,
  author = {Chin, Nicole E and Austin, Andrea Hui},
  title = {Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.7844}
}
Start for free →